Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn moreDeveloping IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn moreDeveloping IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn moreDeveloping IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn moreBringing together unparalleled healthcare data, advanced analytics, innovative technologies, and healthcare expertise to create intelligent connections that speed the development and commercialization of innovative medicines to improve patient lives.
Learn MoreAccelerate digital innovation to enable smarter decisions that reduce cost, modernize patient and consumer engagement, and improve health outcomes.
Learn MoreYour world is unique – and quite different from pharma. In the U.S., decision-making has shifted from individual physicians to integrated networks--GPOs, IDNs and payers. These groups have heightened the focus on proving your solution’s value, demanding outcomes analyses and putting pressure on pricing.
Learn MoreFor government agencies and organizations at every level—from federal or national to regional and local—Big Data can have a huge impact on public health.
Learn MoreA curation of IQVIA's best thinking on topics and trends driving change, disruption, and progress in the United States healthcare market.
LEARN MOREGet the latest insights on our life sciences, healthcare, and medical technology solutions in the United States. Follow our blog today!
LEARN MOREThe continued growth and investment by commercial pharma organizations in new customer engagement and omnichannel capabilities is showing no signs of slowing down. The pandemic increased healthcare professionals’ (HCP’s) digital maturity and comfort levels, while accelerating life sciences companies’ investment in and adoption of digital and virtual channels.
In this webinar, we’ll explore how shifting dynamics in the healthcare ecosystem are driving the need to rethink how investment decisions are made. Now, more than ever, it is crucial that commercial investment decisions take an integrated approach that account for both HCP and patient promotional efforts, as well as payer controls.
Matthew Smith
Senior Principal, New Commercial Models & Digital Health, IQVIA
Christie Conn
Vice President, Brand & Commercial Strategy, IQVIA
Pankaj Gupta
Senior Principal, Offering Design Team, IQVIA
Harini Raman
Associate Principal, Digital Enablement, IQVIA